Page last updated: 2024-08-18

pyrroles and Hallucinations

pyrroles has been researched along with Hallucinations in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banerjee, A; Blaney, S; Boyett, JM; Friedman, H; Fruscio, R; Geyer, R; Goldman, S; Kieran, MW; Kun, LE; Macdonald, T; Packer, R; Phillips, P; Pollack, I; Poussaint, TY; Supko, JG; Wallace, D	1

Trials

1 trial(s) available for pyrroles and Hallucinations

Article	Year
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatric blood & cancer, 2009, Volume: 52, Issue:2 Topics: Adolescent; Angiogenesis Inhibitors; Anticonvulsants; Arthralgia; Central Nervous System Neoplasms; Child; Drug Interactions; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Liver; Male; Maximum Tolerated Dose; Protein Kinase Inhibitors; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Treatment Outcome; Young Adult	2009

Article

Year

Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.

Pediatric blood & cancer, 2009, Volume: 52, Issue:2

Topics: Adolescent; Angiogenesis Inhibitors; Anticonvulsants; Arthralgia; Central Nervous System Neoplasms; Child; Drug Interactions; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Liver; Male; Maximum Tolerated Dose; Protein Kinase Inhibitors; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Treatment Outcome; Young Adult

2009